 |
 |

Effects of Temporal Variability on P50 and the Gating Ratio in Schizophrenia
A Frequency Domain Adaptive Filter Single-Trial Analysis
Julie V. Patterson, PhD;
Yi Jin, MD;
Matt Gierczak, BS;
William P. Hetrick, PhD;
Steven Potkin, MD;
William E. Bunney, Jr, MD;
Curt A. Sandman, PhD
Arch Gen Psychiatry. 2000;57:57-64.
Background Deficits in attention and cognition are common in schizophrenia. Using an auditory dual-click paradigm, a number of studies have found that, compared with normal controls, patients with schizophrenia show impaired inhibition, or gating, of repeated stimulation as measured by the average P50 evoked response to the second click. Since responses to many trials are collected to study the average response, fluctuations in the timing of the P50 response from trial to trial may influence the differences observed. We present a computerized, objective procedure that evaluates temporal variability in brain responses of patients with schizophrenia.
Methods Ten normal controls and 10 patients diagnosed with schizophrenia were studied using the dual-click procedure. For each single trial, the temporal shift in P50 that yielded the best alignment with the average P50 response was used to derive a measure of P50 temporal variability from trial to trial and to form P50 averages corrected for temporal variability.
Results Patients with schizophrenia had significantly more temporal variability than normal controls. Correction for temporal variability in the P50 responses increased the size of P50 for both patients with schizophrenia and normal controls. Patients with schizophrenia had smaller P50 responses to the first click than controls and less inhibition to the second click before, but not after, correction for temporal variability.
Conclusions These findings suggest that temporal variability contributes significantly to the P50 response as measured using the gating procedure. The measure of temporal variability may provide a new index of inhibitory and attentional function in schizophrenia.
From the Departments of Neurology (Dr Patterson) and Psychiatry and Human Behavior (Drs Jin, Potkin, Bunney, and Sandman), University of California, Irvine; MIG Systems Engineering, Costa Mesa, Calif (Mr Gierczak); and the Department of Psychology, University of Indiana, Bloomington (Dr Hetrick).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Sensory Gating Endophenotype Based on Its Neural Oscillatory Pattern and Heritability Estimate
Hong et al.
Arch Gen Psychiatry 2008;65:1008-1016.
ABSTRACT
| FULL TEXT
Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle
Halene and Siegel
J. Pharmacol. Exp. Ther. 2008;326:230-239.
ABSTRACT
| FULL TEXT
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky et al.
Schizophr Bull 2007;33:69-94.
ABSTRACT
| FULL TEXT
Dysregulation of thalamic sensory 'transmission' in schizophrenia: neurochemical vulnerability to hallucinations
Behrendt
J Psychopharmacol 2006;20:356-372.
ABSTRACT
Association of Promoter Variants in the {alpha}7 Nicotinic Acetylcholine Receptor Subunit Gene With an Inhibitory Deficit Found in Schizophrenia
Leonard et al.
Arch Gen Psychiatry 2002;59:1085-1096.
ABSTRACT
| FULL TEXT
|